The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study
- Authors: Gostishchev RV1, Soboleva GN1, Samko AN1, Rogoza AN1, Minasyan AA1
-
Affiliations:
- Federal State Budgetary Institution "National Medical Research Center of Cardiology" of the Ministry of Health of Russia
- Issue: Vol 90, No 9 (2018)
- Pages: 53-59
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32990
- DOI: https://doi.org/10.26442/terarkh201890953-59
- ID: 32990
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
R V Gostishchev
Federal State Budgetary Institution "National Medical Research Center of Cardiology" of the Ministry of Health of Russia
Email: gostiroman@gmail.com
аспирант отд. рентгенэндоваскулярных методов диагностики и лечения НИИ клинической кардиологии им. А.Л. Мясникова Moscow, Russia
G N Soboleva
Federal State Budgetary Institution "National Medical Research Center of Cardiology" of the Ministry of Health of Russiaд.м.н., в.н.с. отд. ангиологии НИИ клинической кардиологии им. А.Л. Мясникова Moscow, Russia
A N Samko
Federal State Budgetary Institution "National Medical Research Center of Cardiology" of the Ministry of Health of Russiaд.м.н., проф., руководитель отд. рентгенэндоваскулярных методов диагностики и лечения НИИ клинической кардиологии им. А.Л. Мясникова Moscow, Russia
A N Rogoza
Federal State Budgetary Institution "National Medical Research Center of Cardiology" of the Ministry of Health of Russiaд.б.н., проф., руководитель отд. новых методов диагностики ФГБУ НМИЦК М3 РФ Moscow, Russia
A A Minasyan
Federal State Budgetary Institution "National Medical Research Center of Cardiology" of the Ministry of Health of Russiaординатор НИИ клинической кардиологии им. А.Л. Мясникова Moscow, Russia
References
- Sarno G, Lagerqvist B, Fröbert O, et al. Lower risk of stent thrombosis and restenosis with unrestricted use of "new - generation" drug - eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2012;33(5):606-13. doi: 10.1093/eurheartj/ehr479
- Жамгырчиев Ш.Т., Фетцер Д.В., Першуков И.В., Левицкий И.В., Самко А.Н., Батыралиев Т.А. Клиническое значение коронарных стентов с лекарственным покрытием. Терапевтический архив. 2007;9:79-84
- Самко А.Н., Лупанов В.П., Бакашвили Г.Н., Матчин Ю.Г., Левицкий И.В. Ближайшие и отдаленные результаты применения стентов с лекарственным покрытием эверолимусом Promus и сиролимусом Cypher у больных ИБС с коронарным атеросклерозом. Международный журнал интервенционной кардиоангиологии. 2012;29:9-18.
- Nallamothu B.K, Chetcuti S, Mukherjee D, Grossman P.M, Kline-Rogers E, Werns S.W, Bates E.R, Moscucci M. Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol. 2003;91:1272-4.
- Kini A.S, Lee P, Marmur J.D, Agarwal A, Duffy M.E, Kim M.C, Sharma S.K. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid - term mortality. Am J Cardiol. 2004;93:18-23.
- Cavallini C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, Rubartelli P, Battaglia S, Niccoli L, Steffenino G, Ardissino D. Impact of the elevation of biochemical markers of myocardial damage on long-103term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J. 2005;26:1494-8.
- Tricoci P, Leonardi S, White J, White H.D, Armstrong P.W, Montalescot G, Giugliano R.P, Gibson C.M, Van de Werf F, Califf R.M, Harrington R.A, Braunwald E, Mahaffey K.W, Newby L.K. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. J Am Coll Cardiol. 2013 Jul 16;62(3):242-51. doi: 10.1016/j.jacc.2013.04.043. Epub 2013 May 15
- Saadeddin S.M, Habbab M.A, Siddieg H.H, Al Seeni M.N, Tahery A.B, Dafterdar R.M. Evaluation of 6 cardiac troponin assays in patients with acute coronary syndrome. Saudi Med J. 2003 Oct;24(10):1092-7.
- Кардиоваскулярная профилактика. Национальные рекомендации. Кардиоваскулярная терапия и профилактика. 2011;10(6). Приложение 2
- Imagawa J, Baxter G.F, Yellon D.M. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol. 1998 Jan;31(1):74-9.
- Lee H.C, An S.G, Choi J.H, Lee T.K, Kim J, Kim J.H, Chun K.J, Hong T.J, Shin Y.W, Lee S.K. Effect of intra - coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction. Circ J. 2008 Sep;72(9):1425-9.
- Ishida H, Higashijima N, Hirota Y, Genka C, Nakazawa H, Nakaya H, Sato T. Nicorandil attenuates the mitochondrial Ca2+ overload with accompanying depolarization of the mitochondrial membrane in the heart. Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):192-7. Epub 2003 Dec 18.
- Thygesen K, Alpert J, Jaffe A, Simoons M, Chaitman B, et al. Third universal definition of myocardial infarction. European Heart J. 2012;33:2551-67.
- Miller W.L, Garratt K.N, Burritt M.F, Reeder G.S, Jaffe A.S. Timing of peak troponin T andcreatine kinase-MB elevations after percutaneous coronary intervention. Chest. 2004;25:275-80.
- Lansky A.J, Stone G.W.Periprocedural myocardial infarction:prevalence, prognosis and prevention. Circ Cardiovasc Interv. 2010;3:602-10.
- Cavallini C, Verdecchia P, Savonitto S, Arraiz G, Violini R, Olivari Z, Rubartelli P, De Servi S, Plebani M, Steffenino G, Sbarzaglia P, Ardissino D. Italian Atherosclerosis, Thrombosis and Vascular Biology and Society for Invasive Cardiology-GISE Investigators Prognostic value of isolated Troponin I elevation after Percutaneous coronary intervention. Circ Cardiovasc Interv. 2010;3:431-5.
- Simoons M.L, van den Brand M, Lincoff M, et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J. 1999;20:1112-29.
- Abdelmeguid A.E, Topol E.J, Whitlow P.L, et al. Significance of mild transient release of creatineki - nase-MB fraction after percutaneous coronary interventions. Circulation. 1996; 94:1528-36.
- Brener S.J, Ellis S.G, Schneider J, Topol E.J. Frequency and longterm impact of myonecrosis after coronary stenting. Eur Heart J. 2002;23:869-76.
- Novack V, Pencina M, Cohen D.J, et al. Troponin criteria for myocardial infarction after percuta - neous coronary intervention. Arch Intern Med. 2012;172:502-8.
- Tardiff B.E, Califf R.M, Tcheng J.E, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol. 1999;33:88-96.
- Harris B.M, Nageh T, Marsden J.T, Thomas M.R, Sherwood R.A. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem. 2000;37:764-9.
- Januzzi J.L, Lewandrowski K, Mac Gillivray T.E, Newell J.B, Kathiresan S, Servoss S.J, Lee-Lewandrowski E. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002;39:1518-23.
- Laugaudin G, Kuster N, Petiton A, Leclercq F, Gervasoni R, Macia J.C, Cung T.T, Dupuy A.M, Solecki K, Lattuca B, Cade S, Cransac F, Cristol JP, Roubille F. Kinetics of high - sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention. European Heart J: Acute Cardiovascular Care. 2016;5(4):354-63.
- Murry C.E, Jenning R.D, Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1122-36.
- Kloner R.A, Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: Part 1. Circulation. 2001;104(24):2981-9.
- Kloner R.A, Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: Part 2. Circulation. 2001;104(25):3158-67.
- Гостищев Р.В., Соболева Г.Н., Самко А.Н., Осиев А.Г. Фармакологическое прекондиционирование: в фокусе - никорандил. Российский кардиологический журнал. 2017;8:114-21 doi: 10.15829/1560-4071- 2017-8-114-121
- Kloner R.A, Yellon D. Does ischemic preconditioning occur in patients? JACC. 1994;24(4):1333-42.
- Turer A.T, Hill J.A. Pathogenesis of myocardial ischemia - reperfusion injury and rationale for therapy. Am J Cardiol. 2010;106:360-8.
- Kharbanda R.K. Cardiac conditioning: a review of evolving strategies to reduce ischemia - reperfusion injury. Heart. 2010;96:1179-86.
- Лупанов В.П., Максименко А.В. Протективная ишемия в кардиологии. Формы кондиционирования миокарда. Кардиоваскулярная терапия и профилактика. 2011;10(1)
- Hausenloy D.J, Ong S.B, Yellon D.M. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol. 2009;104(2):189-202.
- Писаренко О.И. Ишемическое прекондиционирование: от теории к практике. Кардиология. 2005;9:62-72
- Бойцов С.А. Патогенез хронической формы ишемической болезни сердца. В кн.: Руководство по атеросклерозу и ишемической болезни сердца (под ред. акад. Е.И. Чазова). Москва: Медиа Медика, 2007:330-348
- Ломиворотов В.В., Пономарев Д.Н., Шмырев В.А. и др. Применение дистанционного ишемического прекондиционирования у кардиохирургических больных. Общая реаниматология. 2011;7(3):63-9
- Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment - elevation myocardial infarction. Circulation. 2005 Aug 30;112(9):1284-8.
- Ono H, Osanai T, Ishizaka H, Hanada H, Kamada T, Onodera H, Fujita N, Sasaki S, Matsunaga T, Okumura K. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J. 2004 Oct;148(4):E15.
- Ota S, Nishikawa H, Takeuchi M, Nakajima K, Nakamura T, Okamoto S, Setsuda M, Makino K, Yamakado T, Nakano T. Impact of Nicorandil to Prevent Reperfusion Injury in Patients With Acute Myocardial Infarction Sigmart Multicenter Angioplasty Revascularization Trial (SMART). Circ J. 2006;70:1099-104.
- Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, et al. Long - term nicorandil therapy improves cardiac sympathetic nerve activity after reperfusion therapy in patients with first acute myocardial infarction. J Nucl Med. 2007;48:1676-82.
- Sakata Y, Nakatani D, Shimizu M, Suna S, Usami M, Matsumoto S, Hara M, Sumitsuji S, Kawano S, Iwakura K, Hamasaki T, Sato H, Nanto S, Hori M, Komuro I. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction. J Cardiol. 2012 Jan;59(1):14-21. doi: 10.1016/j.jjcc.2011.08.001. Epub 2011 Sep 15.
- Yang J, Zhang J, Cui W, et al. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention. Anatolian J Cardiol. 2015;15:125-31.
- Izumiya Y, Kojima S, Kojima S, et al. Long - term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris. Atherosclerosis. 2011;214:415-21.
- Kawai Y, Hisamatsu K, Matsubara H, Dan K, Akagi S, Miyaji K, Munemasa M, Fujimoto Y, Kusano K.F, Ohe T. Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon. Eur Heart J. 2009 Apr;30(7):765-72. doi: 10.1093/eurheartj/ehp077. Epub 2009 Mar 10.
- Isono T, Kamihata H, Sutani Y, Motohiro M, Yamamoto S, Kyoui S, Iharada Y, Kurimoto K, Hara K, Takahashi H, Iwasaka T. Nicorandil suppressed myocardial injury after percutaneous coronary intervention. Int J Cardiol. 2008 Jan 11;123(2):123-8. Epub 2007 Mar 8.
- Hirohata A, Yamamoto K, Hirose E, Kobayashi Y, Takafuji H, Sano F, Matsumoto K, Ohara M, Yoshioka R, Takinami H, Ohe T. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study. Euro Intervention. 2014 Jan 22;9(9):1050-6. doi: 10.4244/EIJV9I9A178
- Holmvang L, Jurlander B, Rasmussen C, Thiis J.J, Grande P, Clemmensen P. Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. Chest. 2002;121:103-11.
![](/img/style/loading.gif)